Anticipated correlation between lean body mass to visceral fat mass ratio and insulin resistance: NHANES 2011-2018
暂无分享,去创建一个
Huiqin Zhong | Ya Shao | Longti Li | Xiaojun Wang | Yu Hua | Xu Zhou
[1] Xia Li,et al. Fat-to-muscle ratio is associated with insulin resistance and cardiometabolic disorders in adults with type 1 diabetes mellitus. , 2023, Diabetes, obesity & metabolism.
[2] Lin F. Yang,et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 , 2023, The Lancet.
[3] J. Després,et al. BMI versus obesity subtypes in the era of precision medicine. , 2023, The lancet. Diabetes & endocrinology.
[4] Yanting Zhou,et al. Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes , 2023, Frontiers in Endocrinology.
[5] Yingli Lu,et al. Age‐specific and sex‐specific associations of visceral adipose tissue mass and fat‐to‐muscle mass ratio with risk of mortality , 2022, Journal of cachexia, sarcopenia and muscle.
[6] Xiujun Li,et al. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis , 2022, Cardiovascular Diabetology.
[7] M. Davies,et al. Type 2 diabetes , 2022, The Lancet.
[8] Hanmei Xu,et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy , 2022, Signal Transduction and Targeted Therapy.
[9] Huilei Zhao,et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis , 2022, Cardiovascular Diabetology.
[10] Wei Li,et al. Association Between Fat Mass to Lean Body Mass Ratio and All-Cause Mortality Among Middle-Aged and Elderly Cancer Patients Without Obesity: A Multi-Center Observational Study in China , 2022, Frontiers in Nutrition.
[11] Yu Xu,et al. Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study , 2022, Diabetes care.
[12] D. Magliano,et al. The burden and risks of emerging complications of diabetes mellitus , 2022, Nature Reviews Endocrinology.
[13] Wei-liang Chen,et al. Not the enemy: superficial subcutaneous adipose tissue may bring protective benefits. , 2022, Polish archives of internal medicine.
[14] L. Moreno,et al. Fat-free/lean body mass in children with insulin resistance or metabolic syndrome: a systematic review and meta-analysis , 2022, BMC Pediatrics.
[15] J. Olefsky,et al. Inflammation in obesity, diabetes, and related disorders. , 2022, Immunity.
[16] L. Peng,et al. Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity , 2021, Journal of cachexia, sarcopenia and muscle.
[17] B. Duncan,et al. IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.
[18] V. Malik,et al. An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective. , 2021, Endocrinology and metabolism clinics of North America.
[19] J. Després,et al. Management of Obesity in Cardiovascular Practice: JACC Focus Seminar. , 2021, Journal of the American College of Cardiology.
[20] James D. Johnson. On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes , 2021, Diabetologia.
[21] J. Sowers,et al. Obesity, Adipose Tissue and Vascular Dysfunction. , 2021, Circulation research.
[22] M. Buman,et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour , 2020, British Journal of Sports Medicine.
[23] Ji-Won Lee,et al. Inverse association between triglyceride glucose index and muscle mass in Korean adults: 2008–2011 KNHANES , 2020, Lipids in health and disease.
[24] S. Alkahtani,et al. Sarcopenia Coexisting with High Adiposity Exacerbates Insulin Resistance and Dyslipidemia in Saudi Adult Men , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.
[25] N. Stefan. Causes, consequences, and treatment of metabolically unhealthy fat distribution. , 2020, The lancet. Diabetes & endocrinology.
[26] J. Eriksson,et al. Lean body mass is not beneficial, but may be detrimental for glucose tolerance - Splitting body mass index according to body composition. , 2020, Primary care diabetes.
[27] C. Ballantyne,et al. Metabolic Inflammation and Insulin Resistance in Obesity , 2020, Circulation research.
[28] Deqiang Zheng,et al. Relationship of obesity to adipose tissue insulin resistance , 2020, BMJ Open Diabetes Research & Care.
[29] L. Donini,et al. Sarcopenic obesity and insulin resistance: Application of novel body composition models. , 2020, Nutrition.
[30] Y. Song,et al. Fat‐to‐muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults , 2020, Journal of cachexia, sarcopenia and muscle.
[31] M. Brochu,et al. A counterintuitive perspective for the role of fat‐free mass in metabolic health , 2020, Journal of cachexia, sarcopenia and muscle.
[32] S. Lai,et al. Association of insulin resistance and β-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. , 2019, The lancet. Diabetes & endocrinology.
[33] Hailey R Banack,et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. , 2019, European heart journal.
[34] L. Heilbronn,et al. Longitudinal Changes in Insulin Resistance in Normal Weight, Overweight and Obese Individuals , 2019, Journal of clinical medicine.
[35] S. Liatis,et al. Obesity and cardiovascular disease: revisiting an old relationship. , 2019, Metabolism: clinical and experimental.
[36] D. Kim,et al. The Association of Adiponectin and Visceral Fat with Insulin Resistance and β-Cell Dysfunction , 2018, Journal of Korean medical science.
[37] G. Shulman,et al. Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.
[38] M. Brochu,et al. Fat-free mass and glucose homeostasis: is greater fat-free mass an independent predictor of insulin resistance? , 2018, Aging Clinical and Experimental Research.
[39] F. Blyth,et al. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project , 2018, Experimental Gerontology.
[40] Y. Bao,et al. Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes? , 2018, Cardiovascular Diabetology.
[41] T. Funahashi,et al. Association of Epicardial, Visceral, and Subcutaneous Fat With Cardiometabolic Diseases. , 2017, Circulation journal : official journal of the Japanese Circulation Society.
[42] S. Kaneko,et al. Weight-adjusted lean body mass and calf circumference are protective against obesity-associated insulin resistance and metabolic abnormalities , 2017, Heliyon.
[43] A. Hermann,et al. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls , 2016, Acta obstetricia et gynecologica Scandinavica.
[44] M. Brochu,et al. Association between fat free mass and glucose homeostasis: Common knowledge revisited , 2016, Ageing Research Reviews.
[45] Y. Hwang,et al. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype , 2016, Cardiovascular Diabetology.
[46] A. Greenberg,et al. Sex differences in human adipose tissues – the biology of pear shape , 2012, Biology of Sex Differences.
[47] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[48] D. Hu,et al. Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis. , 2017, Clinica chimica acta; international journal of clinical chemistry.